Geoffrey Beran Rose - Mar 1, 2024 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Lauren Cristina, Attorney-in-Fact
Stock symbol
LUNG
Transactions as of
Mar 1, 2024
Transactions value $
-$28,059
Form type
4
Date filed
3/5/2024, 06:22 PM
Previous filing
Feb 26, 2024
Next filing
Mar 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale -$3.88K -428 -0.18% $9.06 243K Mar 1, 2024 Direct F1
transaction LUNG Common Stock Sale -$6.82K -753 -0.31% $9.06 242K Mar 1, 2024 Direct F2
transaction LUNG Common Stock Sale -$17.4K -1.92K -0.79% $9.06 240K Mar 1, 2024 Direct F3
transaction LUNG Common Stock Award $0 +34.5K +14.38% $0.00 274K Mar 1, 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +69.1K $0.00 69.1K Mar 1, 2024 Common Stock 69.1K $9.30 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F4 Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
F5 The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.